OLIGOMET: Outcomes of local treatment for oligometastatic prostate cancer diagnosed using PSMA PET imaging: OLIGOMET study
📢 Exciting news! The database for the OLIGOMET study is now LIVE. Inclusion has officially started!
#OLIGOMET #StudyLaunch #EAURF
#Phoenix milestone: 500 patients recruited.
We are halfway there!
Congratulations to all who have contributed. Keep up the good work.
EAUrf retweeted
Fantastic presentation by @AlexBCDNg at #EAU23 on the PRIME Study ⭐️
✅ Background to PRIME ⚡️
✅ Recruitment over the past year 🏃🏽
✅ Implications of PRIME 🧠
@Uroweb @ESRUrology @EAUYAUrology @EAUrf @eau_yuo #UroSoMe
EAUrf retweeted
#venus study investigator meeting with an all star steam🤩@lopez_fando @echartierkastle @DrFrancoisHerve @FrankVanderAa5 @EAUrf
So excited to learn that we should hit the target of 150 patients recruited before the end of the year #eau23@jncorny
We are delighted to announce that we have reached another Milestone: 100 patients included! #VENUSRegistry (AUS Surgery for Female SUI due to ISD)
Congratulations to all participating study members, this would not be possible without you!
We are happy to announce that study recruitment is over halfway mark of 75 patients! #VENUSRegistry (AUS Surgery for Female SUI due to ISD)
Target of 1000 patients reached in #SATURNRegistry (Surgery for Male Stress Urinary Incontinence)! Congrats to all particpating investigators and staff members. Thank you all for making this registry a great success!
Good news!
Dr. Koen van Renterghem from Hasselt, Belgium, has enrolled the first two patients in the Phoenix registry.
Congratulations Koen!
We are off to a good start, with hopefully many more patients to come.
Kind regards,
On behalf of the Phoenix team
EAUrf retweeted
Seeking funding for your exploratory research?
The @EAUrf’s seeding grants of up to € 25,000 allow young investigators with ideas for highly innovative research to start working on their projects.
Deadline for applications: 31 March.
Full details👇
uroweb.org/eau-rf-seeding-gr…
750th patient enrolled for #SATURNRegistry (Surgery for Male Stress Urinary Incontinence) at Guy’s Hospital, London, UK
EAUrf retweeted
EUPROMS study: "Initial treatment is often followed by subsequent treatments, affecting mainly sexual function, as well as fatigue and insomnia."
#EarlyDetection and AS are the best ways to preserve the QoL of those affected by #ProstateCancer.
👇
sciencedirect.com/science/ar…
Update on #SATURNRegistry (Surgery for Male Stress Urinary Incontinence) presented by Prof. Frank Van der Aa at #EAU20. See webcast/poster at Poster Session: The iatrogenic blues of male stress incontinence, are we out of the dark ages? Abstract 269.
Results from the #NIMBUSstudy (reduced frequency BCG instillations in NMIBC) presented at Game Changing Session 2 #EAU20 Saturday 18 July 8.30.
EAUrf retweeted
Happy to announce that the very 1st patient has been included in the VENUS study, the 1st international prospective multicenter study on artificial urinary sphincter implantation in female patients. Congrats to @lopez_fando 🇪🇸& its team! @EAUrf #NCT04114266
150 patients enrolled at the @UZLeuven for #SATURNRegistry (Surgery for Male Stress Urinary Incontinence). We congratulate Prof. Frank Van der Aa and his team members!
First patient enrolled for #VENUSRegistry (AUS Surgery for Female SUI due to ISD) at the Hospital Ramón y Cajal in Madrid, Spain. We congratulate Dr. Luis López-Fando Lavalle and his team members!
First site (Fondazione IRCCS Istituto Nazionale dei Tumori, Milano, Italy) initiated for EAU RF Pegasus study (Safety and Efficacy of Pemigatinib in Patients With High-risk Urothelial Cancer After Radical Surgery)#andreanecchi #trialPegasus












